Overview of Poster Sessions
POSTER SESSION I – SUNDAY, FEBRUARY 27, 2005 – 5:30 P.M. TO 7:00 P.M
Basic Neuroscience
• | P1. Zinc-containing amygdaloid efferents to medial prefrontal cortex: histochemical characterization and implications in development. Heather M. Ames, Mette K. Christensen, Jens Christian Sorensen, Francine M. Benes, Miles G. Cunningham | ||||
• | P2. Engraftment of GABAergic neurons into the amygdala attenuates anxiety in the unconditioned light response. Miles G. Cunningham, Caroline M. Connor, Rachael A. Donalds, Edward G. Meloni, Mark S. Todtenkopf, Douglas B. Jacoby, William A. Carlezon. | ||||
• | P3. Transplantation of a monoaminergic cell line into an animal model of depression. Rachael A. Donalds, Dong-Wook Kim, Caroline M. Connor, Susan Anderson, Lee Napierata, Kwang-Soo Kim, Miles G. Cunningham. | ||||
• | P4. Viral tracers and the cerebellum: parallel circuits for neuropsychiatric function. Katherine H. Taber, Peter L. Strick, Robin A. Hurley. | ||||
• | P5. Convergence of amygdalofugal and TH-positive fibers within the adult and developing cingulate cortex. Olga Osadchaya, Francine M. Benes, Miles G. Cunningham. | ||||
• | P6. Corticothalamic connections of the posteromedial cortex in the macaque: implications for the understanding of consciousness and psychosis. Josef Parvizi, Gary W. Van Hoesen, Joseph Buckwalter. |
Dementia
• | P7. Clinical utility of the Frontal Assessment Battery (FAB) in older adults with suspected Alzheimer’s dementia. Brian L. Brooks, Grant L. Iverson. | ||||
• | P8. Measuring change on the Cornell Scale for Depression in Dementia. Grant L. Iverson, Rael T. Lange. | ||||
• | P9. Interpreting change on factor scores for the Neuropsychiatric Inventory-Nursing Home Version. Grant L. Iverson. | ||||
• | P10. Cognitive decline following single known stroke. Gregory Kellermeyer, Nancy M. Bonifer, Kristin M. Anderson, C. Alan Anderson, David B. Arciniegas | ||||
• | P11. NPI behavioral disorder frequencies are similar in DSM-IV-TR and NINCDS-ADRDA severe Alzheimer’s disease in a dementia facility population. Edward C. Lauterbach, Aderonke A. Oguntoye, Angela D. Losert, Samuel D. Shillcutt. | ||||
• | P12. Assessment of apathy and depression prevalence in DSM-IV-TR and NINCDS-ADRDA Alzheimer’s disease at a dementia nursing facility. Edward C. Lauterbach, Aderonke A. Oguntoye, Angela D..Losert, Samuel D. Shillcutt. | ||||
• | P13. Insight in MCI and AD and assessment of quality of life. Rebecca E. Ready, Brian R. Ott, Janet Grace | ||||
• | P14. Predictors of caregiver desire to institutionalize. Mary B. Spitznagel, Geoffrey Tremont, Jennifer D. Davis, Suzanne M. Foster | ||||
• | P15. Relationship satisfaction affects caregiver burden in dementia caregivers. Pamela Steadman, Geoffrey Tremont, Jennifer Davis | ||||
• | P16. High prevalence of impaired graphesthesia in patients with mild cognitive impairment (mci). Edward Zamrini, Atiq Rhaman, Troy Anderson |
Epilepsy
• | P17. Magnetoencephalography aids in neuroanotomic localization of electrophysiologic abnormalities in pediatric epilepsy. Daniel J. Abrams, Paul M. Levisohn, Pramote Laoprasert, Daniel A. Collins, Donald C. Rojas, Martin L. Reite |
Imaging
• | P18. Hippocampus volume loss in alcoholism: a replication study. Thomas P. Beresford, David B. Arciniegas, Julie Alfers, Lori Clapp, Brandon Martin | ||||
• | P19. Cortisol and vulnerability to hippocampus volume loss in alcoholism. Thomas P. Beresford, David B. Arciniegas, Julie Alfers, Lori Clapp, Mark Laudenslager, Brandon Martin | ||||
• | P20. Quantitative pharmacological fmri: a new approach and test of concept. Kevin J. Black, Jacob M. Poulsen, Jonathan M. Koller, Stacie L. Warren, Johanna M. Hartlein | ||||
• | P21. Neuropsychiatry in frontotemporal degeneration correlates with right-sided regional atrophy. Tiffany W. Chow, Malcolm A. Binns, Joel Ramirez, Sandra E. Black | ||||
• | P22. Impact of diagnosis of personality disorder on gray matter volumes in first-episode schizophrenia: a preliminary Voxel-Based Morphometric Analysis. Harpreet S. Duggal, Matcheri S. Keshavan, Jeffery Nutche | ||||
• | P23. Anxiety and regional cortical metabolism in patients with Alzheimer’s disease?. Hiroshi Hashimoto, Lorena Monserratt, Peter Nguyen, Denise Feil, Dylan Harwood, Mark Mandelkern, David Sultze | ||||
• | P24. Volitional action as assessed by magnetoencephalography. Benzi M. Kluger, Donald C. Rojas, Eugene Kronberg, Christopher M. Filley | ||||
• | P25. Donepezil and placebo effects on brain networks and cognition Parkinson’s disease. Marc J. Mentis, Luke Donetelli, Dominique, Delalot, Paul Mattis, Mark Gordon, Vijay Dhawan, David Eidelberg. | ||||
• | P26. Tissue abnormalities in autism detected through voxel-based T2 imaging. Rob Nicolson, Janet Hendry, Timothy DeVito, Neil Gelman, Nagalingam Rajakumar, Peter Williamson, Dick Drost | ||||
• | P27. Interdisciplinary approach for the evaluation of brain SPECT usefulness in optimization of diagnosis and treatment in children with serious learning difficulties and comorbidity. Dan G. Pavel, Paul Cates, Steven Devore-Best, David Woodhouse, Krik Cates, Yu-Ching Chang, Jun Eunsun, Irnina Craita | ||||
• | P28. Brain metabolic correlates of marijuana use: a review of the neuroimaging data. Jeremy Quickfall, David Crockford |
Neuropsychology
• | P29. Borderline Personality Disorder, Impulsivity, and the Orbitofrontal Cortex. Heather A. Berlin, Edmund T. Rolls, Susan D. Iversen. | ||||
• | P30. Can neuropsychological tests predict memory performance on the sodium amytal procedure (Wada)?. Kristine A. Borden, Thomas G. Burns, & Tiffany D. Denton | ||||
• | P31. Neuropsychological aspects of depression subtypes in Parkinson’s disease. Marianne Naomi Findler, Allessandro Di Rocco, John W. Barnhill, James Godbold, Milana D. Veytsman, Oana Petrescu, Lucio Marinelli, Deborah Hesketh, Amy Scarano, Niv Mor, Anne Dalton, Sabina Nasser, Stephen J. Ferrando. | ||||
• | P32. Cognitive performance and quality of life in medication-refractory Parkinson’s disease. N. S. Koven, R. M. Roth, D. J. Coffey, L. A. Flashman, A. J. Saykin | ||||
• | P33. An examination of the neuropsychological properties of the Cognitive Assessment System: a comparison of PASS theory, factor analytic, hierarchical agglomerative cluster analysis and ipsative models in subjects with focal brain lesion. Simon M. McCrea | ||||
• | P34. Comparability of the full and 160-Item Short Form Versions of the Personality Assessment Inventory among patients referred for neuropsychological evaluations: assessing differences in reliability, factor structure, and within-individual agreement. Richard Naugle, Thomas Frazier, Kathryn Haggerty | ||||
• | P35. Theory of mind and decision-making deficits in patients with prefrontal cortex dysfunction. Teresa Torralva, John Hodges, Tristán Bekinschtein, Luke Clark, María Roca, Agustina Lacroze, María Calcagno, Ramón Leiguarda, Facundo Manes | ||||
• | P36. An ecological battery to detect specific executive deficits in patients with early frontal variant of Frontotemporal Dementia (fvFTD). Teresa Torralva | ||||
• | P37. Executive functions in ADHD: the usefulness of an “ecological” battery. Teresa Torralva, Alicia Lischinsky, Agustina Lacroze, María Calcagno, Ramón Leiguarda, Facundo Manes |
Schizophrenia
• | P38. Brain activation patterns associated with listening to trauma-related words and scripts in patients with schizophrenia and posttraumatic stress disorder: a preliminary fMRI study. Laura Fashman, Andrew Saykin, Robert Roth, Robert Vidaver, Matthew Friedman, Paula Schnurr, Thomas McAllister, Kim Mueser, Stanley Rosenberg | ||||
• | P39. A study of frontal executive function using Kims Frontal Executive Function Test in schizophrenia. Jeong-Lan Kim, Kyoung-Ok Lim, IK-Seong Chee, Seong-Kun Wang, Sun-Woo Lee. | ||||
• | P40. Cardiac chaos as a marker of therapeutic response in treatment-resistant schizophrenic subjects treated with clozapine. Jong-Hoon Kim, Sang-Hoon Yi, Yong Min Ahn, Yong Sik Kim |
POSTER SESSION II – TUESDAY, MARCH 1, 2005 – 4:30 P.M. TO 6:00 P.M.
General Clinical Neuropsychiatry
• | P1. Psychiatric comorbidity, disability, and quality of life in psychogenic movement disorder versus Parkinson’s disease. Karen E. Anderson, Ann L. Gruber-Baldini, Christopher G. Vaughan, Stephen G. Reich, Paul Fishman, William J. Weiner, Lisa M. Shulman | ||||
• | P2. Neuroinvasive West Nile Virus infections: neurobehavioral and functional outcomes. David B. Arciniegas, Kimberly Frey, Jeannie L. Topkoff, Kristin M. Brousseau, Eric Hartman, Jeremy Rieks, Miguel Alvarado, Alan Spees, C. Alan Anderson, Donald C. Rojas, Elizabeth Kozora, Kenneth L.Tyler | ||||
• | P3. Towards a collaborative education and treatment of disorders emanating from the central nervous system. Joseph Baskin, Bruce Price, Martin Goldstein, Anthony Joseph, Jennifer Woehr, Rachael Donalds, Miles Cunningham | ||||
• | P4. Neurologic and psychiatric co-morbidity in neuropsychiatry training. R. Andrew Swell, Sheldon Benjamin. | ||||
• | P5. Neurological and neuropsychological abnormalities in imprisoned sexual offenders. Deborah N. Black, Carine Doucet, Benoit Dassylva | ||||
• | P6. Neuropsychiatry as an integrative specialty: paraphrenias and combined subsyndromic presentations in geriatric psychiatry. T. Brashers-Krug, VE Koliatsos | ||||
• | P7. A neuropsychiatric presentation of Lyme disease. Kristin Brousseau, David Iverson | ||||
• | P8. The prevalence of anxiety disorders in a cohort of Multiple Sclerosis patients followed in a neuropsychiatry clinic and the impact of anxiety on the Multiple Sclerosis disease profile. Zeina Chemali, Juan Carlos Urizar | ||||
• | P9. Neuropsychiatry as an integrative specialty for disorders of the peripheral and autonomic nervous system. Thomas N. Franklin, Vassilis E. Koliatsos | ||||
• | P10. Older age immunological measures among HIV-I infected primary Spanish speakers in the USA. Karl Goodkin, Deshratn Asthana, Paul Shapshak, Mauricio Concha, Diana Lee, Sandra O’Mellan, Wenli Zheng, Imad Khamis | ||||
• | P11. Comparative efficacy of extended-release bupropion and escitalopram for major depressive disorder. Joseph P. Horrigan, Jack G. Modell, Donna S. Wightman, Nathalie E. Richard, Alok Krishen. | ||||
• | P12. Neuropsychiatry as an integrative specialty: definitions, patient types, and points of view. Vassilis E. Koliatsos, Robert R. Roca, Steven S. Sharfstein, Ann Newman, Andrew Warren, Thomas Franklin, Thomas Brashers-Krug. | ||||
• | P13. Depression is more strongly associated with subject report than motor signs in PREDICT-HD cohort. Carissa Nehl, Elizabeth A. Penziner, Jane S. Paulsen | ||||
• | P14. Neuromuscular dysfunction and antipsychotic theory. Ilya Reznik, Lior Volchek, Mila Reznik, Avi Weizman, Herbert Y. Meltzer | ||||
• | P15. Psychogenic movement disorder: assessment and antidepressant treatment. Valerie Voon, Anthony E. Lang |
Pediatric Neuropsychiatry/Neuropsychology
• | P16. Insomnia in Tourette syndrome is linked to perinatal factors as well as comorbidities. Marie-Josée Chouinard, Véronique Paradis, Paul Lespérance, Guy Rouleau, Sylvain Chouinard, Francois Richer | ||||
• | P17. Hyperammonemia, carnitine deficiency, cerebral atrophy, and progressive cognitive impairment in three bipolar child patients treated with divalproex sodium. Daniel T. Matthews, Larry Fisher, John Seals | ||||
• | P18. Consequences of abnormal anxiety with congenital central hypoventilation syndrome. Susan Beckwitt Turkel, Maida L. Chen, Julienne R. Jacobson, Thomas G. Keens | ||||
• | P19. The effects of psycho-stimulants on children’s academic achievement in cognitive functioning. Cates Kirk, Cates Paul, Woodhouse David |
Traumatic Brain Injury
• | P20. Effect of age on recovery following severe traumatic brain injury. Benjamin S. Alderfer, Kimberly L. frey, Gergory B. Kellermeyer, Kristin M. BNrousseau, Jeannie L. Topkoff, C. Alan Anderson, Christopher M. Filley, David B. Arciniegas. | ||||
• | P21. Frontal dysfunction is a dominant feature of posttraumatic encephalopathy. Gregory Kellermeyer, Kimberly Frey, Benjamin Alderfer, Jeannie Topkoff, Kristin Brousseau, C.Alan Anderson, Christopher M. Filley, David B. Arciniegas | ||||
• | P22. A prospective study of cognitive enhancement with galantamine increased over four months in patients with traumatic brain injury. John Claude Krusz, Stephen Roberts, Jack Thomson | ||||
• | P23. Donepezil for cognitive enhancement after traumatic brain injury. John Claude Krusz, Alan C. Hopewell, John A. Thomson, Stephen Roberts | ||||
• | P24. Two CHRM2 SNPs modulate working memory performance and anxiety shortly after mild/moderate traumatic brain injury (MTBI). TW McAllister, LA Flashman, CH Rhodes, BC McDonald, DR Belloni, ML Curtis, RB Ferrell, GJ Tsongalis, AJ Saykin. | ||||
• | P25. Use of the frontal systems behavior scale in traumatic brain injury. Sonal Pancholi, Louis French, Farah Said, Laurie Ryan, Deborah Warden | ||||
• | P26. The effect of mild-to-moderate traumatic brain injury and APOE-4 on cognitive outcome in older adults: preliminary results of a two-year longitudinal study. Mark J. Rapoport, Prathiba Shammi, Nathan Herrmann, Andrea L. Phillips, Alex Kiss, Anthony Feinstein. | ||||
• | P27. Hippocampal size correlates with episodic memory performance one month after mild traumatic brain injury. J.L. Sotelo, L.A. Flashman, B.C. McDonald, E.M. Crouse, A.J. Saykin, T.W. McAllister. |